MedTrace Logo

Epigenetics and the Origin of Muscle Insulin Resistance in Humans

NCT01726491 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2018-01-16

No results posted yet for this study

Summary

The investigators are trying to understand the role of DNA (deoxyribonucleic acid) methylation in insulin resistance in skeletal muscle and blood tissues. DNA methylation is a normal chemical process in the body that modifies DNA. By studying this, the investigators hope to better understand the causes of insulin resistance.

Conditions

  • Diabetes Mellitus Type 2 in Obese
  • Obesity

Sponsors & Collaborators

Principal Investigators

  • Lori Roust, MD · Mayo Clinic

  • Dawn K Coletta, Ph.D. · Mayo Clinic

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2016-11-21
Completion
2016-11-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01726491 on ClinicalTrials.gov